UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 23, 2008
NATIONAL HEALTH PARTNERS, INC.
(Exact Name of Small Business Issuer as Specified in Its Charter)
Indiana | | 000-51731 | | 04-3786176 |
State or Other Jurisdiction of Incorporation or Organization) | | (Commission
File Number) | | (IRS Employer
Identification Number) |
| | | | |
120 Gibraltar Road, Suite 107
Horsham, Pennsylvania | | 19044 |
(Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (215) 682-7114
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 7 – Regulation FD
Item 7.01. Regulation FD Disclosure.
National Health Partners, Inc. will be issuing a letter (the “Letter to Shareholders”) to each of its shareholders of record. A copy of the Letter to Shareholders is attached hereto as Exhibit 99.1 and incorporated by reference herein.
Section 9 – Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 Letter to Shareholders
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NATIONAL HEALTH PARTNERS, INC. |
| |
| |
Dated: June 23, 2008 | /s/ David M. Daniels |
| David M. Daniels |
| Chief Executive Officer |
3
EXHIBIT INDEX
Exhibit Number | | Description |
| | |
99.1 | | Letter to Shareholders |
4
